Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ?1 prior tyrosine kinase inhibitor: 2-year follow-up results. - Cortes JE; Sasaki K; Kim DW; Hughes TP; Etienne G; Mauro MJ; Hochhaus A; Lang F; Heinrich MC; Breccia M; Deininger M; Goh YT; et al. (Leukemia, 2024)